Trump to allow certain Nvidia chip sales to China for 25% U.S. cut

The Trump administration will allow Nvidia to sell H200 chips to China while the U.S. government takes a 25% cut of future sales, with sales subject to Commerce Department vetting and national-security conditions. The move, which the president said will be extended to other U.S. chipmakers, echoes an earlier H20 deal (15% revenue share) and restores limited access to the large China market while keeping newer Blackwell chips blocked—potentially boosting addressable sales for legacy chips but reducing vendor take-rates and leaving strategic and defense risks intact.

Analysis

Market structure: The move benefits NVDA, AMD and other GPU makers by opening a constrained incremental China demand pool while preserving the blockade on cutting‑edge Blackwell/Rubin, so pricing power for premium chips remains intact. Expect a near‑term revenue mix shift: if China demand represents 10–20% of addressable GPU sales, incremental H200 shipments could boost unit utilization/near‑term revenue but U.S. government’s 25% take reduces netback and likely compresses gross margins on China sales by mid single‑digits percentage points.

Risk assessment: Tail risks include swift policy reversal, Congressional intervention, or expanded controls to Rubin that would strand inventory — low probability but >10% within 12 months given geopolitics. Immediate (days) reaction will be volatility and re‑rating; short term (1–3 months) depends on Commerce license lists and counterparty approvals; long term (12–24 months) product cadence (H200 obsolescence by H2 2026) limits sustainable China revenue.

Trade implications: Favor convex exposure to NVDA via defined‑risk options (3‑month call spreads 8–12% OTM) sized to 1–3% portfolio to capture upside without funding open puts; consider a relative trade long AMD (6‑month call) vs short INTC equity (1–2% net) as AMD is more comparable for China GPU demand. Reduce duration in defense names sensitive to tech transfer if export windows widen; watch implied vols — expect compression in NVDA/AMD near announcements.

Contrarian angles: The market may underweight the 25% levy’s EPS drag — a 15% China revenue share implies ~3–5% EPS headwind before offsetting volume gains, so base‑case upside may be overstated. Also freer exports for older chips accelerate Chinese self‑development incentives and supply‑chain localization over 2–5 years, which could erode long‑run TAM for U.S. incumbents more than headlines suggest.

Key Decisions for Investors

• Establish a 2–3% long position in NVDA (ticker NVDA) within 1 week and hedge with a 3‑month 10% OTM call spread sized to 1% portfolio notional to capture China re‑open upside while limiting downside; trim if NVDA rallies >15% in two weeks or if Commerce denies >30% of approved customer applications.
• Implement a pair trade: long AMD (AMD) via 6‑month at‑the‑money call (1.5% portfolio) and short INTC equity (1.0% portfolio) to express China GPU upside skewed to chip designers vs legacy CPU exposure; unwind if AMD underperforms NVDA by >8% over 30 trading days or if AMD issues negative China guidance.
• Monitor Commerce license releases and approved customer lists over the next 30–60 days and sell/short NVDA exposure by up to 50% if >40% of targeted China orders are subsequently blocked or if an executive order expands controls to Blackwell/Rubin within 90 days.